E-LIB Suche - Ergebnisse für: Atkins, Michael H.

1

Modeling human yolk sac hematopoiesis with pluripotent stem..:

Atkins, Michael H. ; Scarfò, Rebecca ; McGrath, Kathleen E....
Journal of Experimental Medicine. 219 (2021) 3 - p. , 2021

Link: https://doi.org/10.1084/..

2

Modeling Human Yolk Sac Hematopoiesis with Pluripotent Stem..:

Atkins, Michael H
http://hdl.handle.net/1807/108542. , 2021

Link: http://hdl.handle.net/18..

3

Modeling human yolk sac hematopoiesis with pluripotent stem..:

Atkins, Michael H ; Scarfò, Rebecca ; McGrath, Kathleen E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693237/. , 2021

Link: http://www.ncbi.nlm.nih...

4

Treatment-free survival and partitioned survival analysis o..:

Mantia, Charlene M ; Jegede, Opeyemi A ; Plimack, Elizabeth R...
Journal for ImmunoTherapy of Cancer. 12 (2024) 7 - p. e009495 , 2024

Link: https://doi.org/10.1136/..

5

The use of aprepitant for the prevention of postoperative n..:

Lee, Daniel J. ; Douglas, Jennifer E. ; Chang, Jeremy...
International Forum of Allergy & Rhinology. 13 (2023) 12 - p. 2180-2186 , 2023

Link: https://doi.org/10.1002/..

6

Impact of COVID-19 in patients on active melanoma therapy a..:

Johnson, Douglas B. ; Atkins, Michael B. ; Hennessy, Cassandra...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Real-world treatment patterns and overall survival inBRAF-m..:

Atkins, Michael B ; Julian, Cristina ; Secrest, Matthew H...
Future Oncology. 18 (2022) 18 - p. 2233-2245 , 2022

Link: https://doi.org/10.2217/..

8

Incidence and Durability of SARS-CoV-2 Antibodies in Patien..:

Lai, Catherine ; Potosky, Arnold L. ; McGuire, Colleen...
Journal of Oncology. 2022 (2022) - p. 1-8 , 2022

Link: https://doi.org/10.1155/..

9

Treatment-free Survival after Immune Checkpoint Inhibitor T..:

Regan, Meredith M. ; Jegede, Opeyemi A. ; Mantia, Charlene M....
Clinical Cancer Research. 27 (2021) 24 - p. 6687-6695 , 2021

Link: https://doi.org/10.1158/..

10

Insights from immuno-oncology: the Society for Immunotherap..:

Ascierto, Paolo Antonio ; Fox, Bernard A ; Urba, Walter J...
Journal for ImmunoTherapy of Cancer. 8 (2020) 1 - p. e000878 , 2020

Link: https://doi.org/10.1136/..

11

The society for immunotherapy of cancer consensus statement..:

Rini, Brian I. ; Battle, Dena ; Figlin, Robert A....
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

12

A phase 2, randomized trial evaluating the combination of d..:

Voss, Martin H. ; Bhatt, Rupal S. ; Vogelzang, Nicholas J....
Cancer. 125 (2019) 14 - p. 2400-2408 , 2019

Link: https://doi.org/10.1002/..

13

Updated Recommendations on the Diagnosis, Management, and C..:

Msaouel, Pavlos ; Hong, Andrew L. ; Mullen, Elizabeth A....
Clinical Genitourinary Cancer. 17 (2019) 1 - p. 1-6 , 2019

Link: https://doi.org/10.1016/..

14

An update on the Society for Immunotherapy of Cancer consen..:

Sullivan, Ryan J. ; Atkins, Michael B. ; Kirkwood, John M....
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

15

Toxicities and early outcomes in a phase 1 trial of photody..:

Ahn, Peter H. ; Quon, Harry ; O'Malley, Bert W....
Oral Oncology. 55 (2016) - p. 37-42 , 2016

Link: https://doi.org/10.1016/..